HDL-C in Five Elite Athletes Using Anabolic-Androgenic Steroids
- 1 June 1984
- journal article
- research article
- Published by Taylor & Francis in The Physician and Sportsmedicine
- Vol. 12 (6) , 120-130
- https://doi.org/10.1080/00913847.1984.11701878
Abstract
In brief: High-density lipoprotein cholesterol (HDL-C) levels were measured in five elite weight-trained athletes who were intermittently taking anabolic-androgenic steroids and in 28 age- and sex-matched control subjects who had never taken anabolic-androgenic steroids Athletes had significantly lower levels of HDL C while taking steroids than while abstaining (p <.01). Athletes also had significantly lower HDL-C levels while using steroids than the control subjects (p <.001). Total cholesterol levels for the athletes remained unchanged throughout the study and were similar to control subject levels (p >.05).Keywords
This publication has 10 references indexed in Scilit:
- Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosisPublished by Elsevier ,1982
- High density lipoproteins during hypolipidemic therapyAtherosclerosis, 1980
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- Hyperlipidemia Due to Oxymetholone TherapyPublished by American Medical Association (AMA) ,1976
- Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese MenNew England Journal of Medicine, 1976
- Changing Patterns in Ski InjuriesThe Physician and Sportsmedicine, 1974
- Peliosis Hepatis Associated with Androgenic-Anabolic Steroid TherapyAnnals of Internal Medicine, 1974
- Hepatoma and Peliosis Hepatis Developing in a Patient with Fanconi's AnemiaNew England Journal of Medicine, 1971
- Anabolic Steroid: Effects on Strength DevelopmentScience, 1969
- Metabolic and Serum Lipid Effects of Methylandrostane and Methylandrostene Pyrazoles*Journal of Clinical Endocrinology & Metabolism, 1962